Highlights

  • Inspiration Healthcare Group shares jumped 8.4% on 12 February 2026, followed by company’s FY 26 financial update.
  • Company’s Full-year revenue increased 24% to GBP 47.5 million, exceeding prior year’s GBP 38.3 million.
  • H2 FY26 revenue rose 10.3% to GBP 23.5 million versus GBP 21.3 million in H2 FY25.
  • Adjusted EBITDA is expected to align with current market consensus at GBP 2.8 million.
  • Multi-year purchasing agreement signed with a leading US hospital network via Airon Corporation.
  • Favourable sales momentum expected to continue into FY27 with a solid pipeline of opportunities.

Inspiration Healthcare Group plc (AIM:IHC) shares gained 8.41% to GBX 18.70 during the morning session on 12 February 2026, following the release of its unaudited trading update for the year ended 31 January 2026.

 The update highlighted a 24% increase in full-year revenue to GBP 47.5 million in FY26, slightly above consensus market expectations of GBP 44.1 million, driven by favourable H2 trading performance and operational execution.

H2 FY26 revenue rose 10.3% to GBP 23.5 million, compared with GBP 21.3 million in H2 FY25, reflecting improved sales across the Group and progress under the ‘Back to Basics’ strategy.

Profit Gains and Global Expansion Drive FY26 Performance

Adjusted EBITDA is expected to be in line with market consensus at GBP 2.8 million. The results reflect sales mix effects and stronger operational execution, contributing to growing profits and positive cash flow. Net debt decreased by 39% to GBP 5.1 million, supported by reductions in inventory and receivables

SLE, the Group’s global leader in neonatal ventilation, exceeded management expectations in H2 FY26, following branding realignment and deployment of local distributor managers in Southeast Asia and Latin America. The company is positioned to re-establish its international presence and support overall growth.

Strategic US Agreement Secures Long-Term Revenue

At the end of FY26, Inspiration Healthcare signed a significant three-year purchasing agreement with one of the largest hospital networks in the United States through its subsidiary, Airon Corporation. The agreement includes an initial order of 150 units for Model A and Neo ventilators, as well as ongoing consumables and service revenue, establishing a long-term revenue stream and supporting the Group’s objective of doubling Airon revenue within five years.

 

 

Forward-Looking Momentum Remains in Focus

The Group concluded FY26 with a solid sales pipeline and favourable momentum heading into FY27. Execution of the refreshed strategy across three business units — SLE, Inspiration Healthcare in the UK and Ireland, and Airon globally — positions the company to expand recurring revenue from consumables and service, complementing capital sales.

FAQs

Why did Inspiration Healthcare shares rise 8.41%?

The increase followed FY26 revenue growth of 24% and reduced net debt.

How much did net debt decrease in FY26?

Net debt fell by 39% to GBP 5.1 million from GBP 8.3 million in FY25.

What is the significance of the US hospital agreement?

The three-year contract with Airon secures initial equipment sales and ongoing revenue streams.